Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

P&U antioxidant shows cerebroprotective activity in rats

Aug. 13, 1997

Elan licenses Morphelan to Targon Corporation

Aug. 13, 1997

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

Metabolic studies on sameridine described at ISSX meeting

Aug. 11, 1997

Metabolism of antidepressant studied in vivo

Aug. 11, 1997

Almotriptan metabolic pathway in humans described

Aug. 11, 1997

Mathematical model for predicting S-15535 metabolism in humans

Aug. 11, 1997

Lilly reports new agent for brain injury

Aug. 11, 1997

Tacrine analogs reported for Alzheimer's disease

Aug. 8, 1997

First approval for Elan's Diastat

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...